What Happened

Jason Laut, a paramedic supervisor for MedStar Ambulance Inc. in the Metro East St. Louis area, was charged with falsifying records for years to conceal his theft of fentanyl and morphine from ambulance supplies.

Between January 2013 and May 2015, Laut changed, altered, and falsified documents and records to hide his theft of fentanyl and morphine from MedStar ambulances. Evidence showed he tampered with at least 85 fentanyl vials by puncturing the tamper-resistant packaging with a needle, carefully withdrawing the drug, and replacing it with water or another solution before returning the vials to service.

A federal grand jury in East St. Louis, Illinois, returned a 37-count indictment against Laut on January 18, 2017, charging wire fraud, making false statements, and identity theft. He was later found guilty by a jury on 38 counts, including tampering with a consumer product, and was sentenced on August 21, 2018, to 111 months in federal prison.

What Went Wrong

A supervisor with routine access to ambulance drug boxes was able to tamper with dozens of fentanyl vials and falsify records over more than two years. Key failures included:

  • Tamper-resistant vial packaging was not inspected closely enough to catch a needle puncture used to withdraw and replace the drug.
  • As a supervisor, Laut had the access and authority to alter or falsify the very records meant to catch discrepancies, without independent verification.
  • No routine potency testing of ambulance narcotic stock existed to catch dilution before vials were used on patients.
  • Reconciliation of ambulance drug-box contents against usage and patient care records was insufficiently independent of the person responsible for supervising that stock.

How It Could Have Been Prevented

  • Assign controlled-substance recordkeeping verification to someone independent of the supervisor responsible for the drug stock itself.
  • Inspect tamper-resistant vial seals under magnification or with tamper-detection technology capable of identifying needle punctures.
  • Randomly sample and lab-test ambulance narcotic stock for potency to catch dilution schemes before vials reach patients.
  • Require independent, periodic reconciliation of ambulance drug-box contents against dispatch and patient-care records, not self-reported by the supervising employee.
  • Rotate supervisory oversight of narcotic stock across multiple personnel to prevent single-person control over both the drugs and the records documenting them.

Related Guidance

Sources